IL170997A - Pharmaceutical composition for treatment and prevention of prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits and the process for preparation thereof - Google Patents

Pharmaceutical composition for treatment and prevention of prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits and the process for preparation thereof

Info

Publication number
IL170997A
IL170997A IL170997A IL17099705A IL170997A IL 170997 A IL170997 A IL 170997A IL 170997 A IL170997 A IL 170997A IL 17099705 A IL17099705 A IL 17099705A IL 170997 A IL170997 A IL 170997A
Authority
IL
Israel
Prior art keywords
fatty acids
pharmaceutical composition
acid
obtention
fruits
Prior art date
Application number
IL170997A
Other languages
English (en)
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40210497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL170997(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Publication of IL170997A publication Critical patent/IL170997A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL170997A 2003-03-20 2005-09-20 Pharmaceutical composition for treatment and prevention of prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits and the process for preparation thereof IL170997A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20030062A CU23256A1 (es) 2003-03-20 2003-03-20 EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS
PCT/CU2004/000004 WO2004082696A1 (es) 2003-03-20 2004-03-15 Composición farmacéutica y procedimiento para el tratamiento y prevención de la hiperplasia prostática y la prostatitis a partir de los frutos de roystones regia (palma real)

Publications (1)

Publication Number Publication Date
IL170997A true IL170997A (en) 2010-04-15

Family

ID=40210497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL170997A IL170997A (en) 2003-03-20 2005-09-20 Pharmaceutical composition for treatment and prevention of prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits and the process for preparation thereof

Country Status (24)

Country Link
US (3) US20060228429A1 (enExample)
EP (1) EP1623740B1 (enExample)
JP (1) JP4693766B2 (enExample)
KR (1) KR100758256B1 (enExample)
CN (1) CN100366246C (enExample)
AT (1) ATE394139T1 (enExample)
AU (1) AU2004222693B2 (enExample)
BR (1) BRPI0409056A (enExample)
CA (1) CA2519410C (enExample)
CR (1) CR8001A (enExample)
CU (1) CU23256A1 (enExample)
DE (1) DE602004013572D1 (enExample)
DK (1) DK1623740T3 (enExample)
EC (1) ECSP056028A (enExample)
ES (1) ES2306999T3 (enExample)
IL (1) IL170997A (enExample)
MX (1) MXPA05009905A (enExample)
NO (1) NO333290B1 (enExample)
NZ (1) NZ542361A (enExample)
PT (1) PT1623740E (enExample)
RU (1) RU2331434C2 (enExample)
UA (1) UA82224C2 (enExample)
WO (1) WO2004082696A1 (enExample)
ZA (1) ZA200507575B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4926395B2 (ja) * 2004-11-30 2012-05-09 学校法人 名城大学 抗mrsa用組成物
KR100769412B1 (ko) * 2006-09-13 2007-10-22 주식회사 벤스랩 Pr-119 복합생약 추출물을 함유하는 전립선 비대증의예방 및 치료용조성물
WO2010118362A1 (en) 2009-04-09 2010-10-14 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for inducing physiological hypertrophy
CU24143B1 (es) * 2012-06-19 2016-01-29 Cnic Ct Nac Investigaciones Ingrediente activo para el tratamiento y la prevención de la inflamación y el estrés oxidativo, así como su procedimiento de obtención a partir de los frutos de acrocomina crispa y/o acrocomia aculeata
CA2957363C (en) * 2014-08-12 2022-06-21 Institut de Recherche en Semiochimie et Ethologie Appliquee Palmitoleic acid for use in inhibiting the attachment of sea lice to fish
KR102273967B1 (ko) * 2014-10-31 2021-07-08 (주)아모레퍼시픽 인삼씨유를 함유하여 전립선 비대증을 예방 및 치료하는 조성물
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
JP6628946B2 (ja) 2017-12-26 2020-01-15 大太朗 福岡 増毛、頭皮若しくは皮膚の改質、創傷治癒、骨形成促進、または毛髪の改質に用いるための医薬組成物
AU2019212513B2 (en) 2018-01-26 2024-10-31 Fluidx Medical Technology, Llc Apparatus and method of using in situ solidifying complex coacervates for vascular occlusion
EP4082518A1 (en) 2021-04-28 2022-11-02 Cnce Innovacion, S.L. Fatty acid compositions for the treatment and prevention of hair loss and alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU21519A1 (en) * 1983-03-23 1987-06-09 Inst De Quimica Y Biolog Ex Procedure to facilitate the grinding of roystonea regia fruits
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
CN1184670A (zh) * 1997-12-23 1998-06-17 张冰 一种治疗前列腺增生、前列腺炎的药物组合物
RU2140265C1 (ru) * 1998-10-27 1999-10-27 Чернобаев Николай Евгеньевич Средство для лечения и профилактики доброкачественной гиперплазии простаты (дгп), простатита, импотенции, бесплодия и рака предстательной железы

Also Published As

Publication number Publication date
RU2005130746A (ru) 2006-06-10
ECSP056028A (es) 2006-01-27
DE602004013572D1 (de) 2008-06-19
CN100366246C (zh) 2008-02-06
AU2004222693B2 (en) 2010-08-12
US20100022649A1 (en) 2010-01-28
HK1084059A1 (en) 2006-07-21
KR20050115920A (ko) 2005-12-08
ATE394139T1 (de) 2008-05-15
MXPA05009905A (es) 2006-03-21
UA82224C2 (uk) 2008-03-25
CA2519410A1 (en) 2004-09-30
JP2006520331A (ja) 2006-09-07
US20100021574A1 (en) 2010-01-28
CU23256A1 (es) 2008-01-24
KR100758256B1 (ko) 2007-09-13
AU2004222693A2 (en) 2004-09-30
NO20054847L (no) 2005-10-20
EP1623740A1 (en) 2006-02-08
PT1623740E (pt) 2008-08-12
ES2306999T3 (es) 2008-11-16
CN1761476A (zh) 2006-04-19
US20060228429A1 (en) 2006-10-12
CA2519410C (en) 2011-04-26
BRPI0409056A (pt) 2006-03-28
EP1623740B1 (en) 2008-05-07
JP4693766B2 (ja) 2011-06-01
CR8001A (es) 2006-04-21
DK1623740T3 (da) 2008-09-08
ZA200507575B (en) 2007-03-28
WO2004082696A1 (es) 2004-09-30
NO333290B1 (no) 2013-04-29
NZ542361A (en) 2009-10-30
AU2004222693A1 (en) 2004-09-30
RU2331434C2 (ru) 2008-08-20

Similar Documents

Publication Publication Date Title
AU674710B2 (en) Novel extracts of cucurbita sp., process for their preparation and use in medicaments and in cosmetics
Vali et al. A process for the preparation of food-grade rice bran wax and the determination of its composition
US8030352B2 (en) Method of producing retinyl esters
NO163825B (no) Fremgangsmaate for selektiv anrikning av en fettsyreblanding paa delta6-fettsyrer.
IL170997A (en) Pharmaceutical composition for treatment and prevention of prostatic hyperplasia and prostatitis from the royal palm (roystonea regia) fruits and the process for preparation thereof
EP1248610A2 (fr) Utilisation d'au moins un ester gras pour la preparation d'une composition destinee a inhiber l'activite de la 5 alpha reductase, en pharmacie notamment en dermatologie, en cosmetique et en tant qu'additif alimentaire
JP4335003B2 (ja) ワサビノキ油およびその誘導体を含む超安定組成物およびその使用
Motan et al. Studies of different types of aspirin by spectrophotometric methods
US6348609B1 (en) Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (HODE) or the esters thereof from a mixture containing linoleic acid or the esters thereof
Muhammad et al. Physicochemical characterization and fatty acids composition of four indigenous plant oils
JP2006520331A5 (enExample)
JPH05194250A (ja) サバルセルラタのリピド抽出物の酸分画から導かれた新規薬学的組成物及びその組成物を製造する方法
Wang et al. Enzymatic synthesis of bornyl linoleate in a solvent-free system
CN100478322C (zh) 甲鱼油中ω-3多不饱和脂肪酸的提取方法
JP2004244370A (ja) ニキビ用の皮膚外用剤
KR900002918B1 (ko) 달맞이 꽃 기름의 제조방법
JPS57189650A (en) Hardly water-soluble substance preparation for food
US20150190358A1 (en) Compounds from the fruits of acrocomia crispa and acrocomia aculeata for use against oxidative stress and inflammation
JP2007161630A (ja) 皮脂抑制剤
TW358029B (en) A pharmaceutical composition containing crystalline chelate of zinc with the extract of bovine prostatic tissue for use in the treatment of diabetes mellitus
Parveen et al. Phytochemical analysis of Sida ovata seed oil: a new source of cyclopropenoid fatty acid
Saleem et al. Quantitation of fatty acids by GLC and separation of omega-6 nutraceutical fatty acid from carthamus tinctorius L. seed oil cultivated in Pakistan
CN110559250A (zh) 一种小桐子油基润肤霜及其制备方法
JP2006246743A (ja) 高度不飽和ワックスエステルの製造方法
CN109550276A (zh) 一种提取植物萃取剂

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees